help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-2113
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lambrot, R.
Right arrow Articles by Rouiller-Fabre, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambrot, R.
Right arrow Articles by Rouiller-Fabre, V.
Related Collections
Right arrow Male Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 7 2696-2703
Copyright © 2006 by The Endocrine Society

Use of Organ Culture to Study the Human Fetal Testis Development: Effect of Retinoic Acid

Romain Lambrot, Hervé Coffigny, Catherine Pairault, Anne-Claire Donnadieu, René Frydman, René Habert and Virginie Rouiller-Fabre

Commissariat à l’Energie Atomique, Direction des Sciences du Vivant/Departement de Radiobiologie et Radioprotection/Service d’Etude de la Gamétogenèse et de la Génotoxicité/Laboratory of Differentiation and Radiobiology of the Gonads (R.L., H.C., C.P., R.H., V.R.-F.), Unit of Gametogenesis and Genotoxicity, Institut National de la Santé et de la Recherche Médicale U566 (R.L., H.C., C.P., R.H., V.R.-F.), and University of Paris 7 Denis Diderot (R.L., H.C., C.P., R.H., V.R.-F.), Unité de Formation et Recherche of Biology, F-92265 Fontenay-aux-Roses, France; Assistance Publique-Hôpitaux de Paris (A.-C.D., R.F.), Groupement Hospitalier Universitaire Sud, Hôpital A. Béclère, Service de Gynécologie-Obstétrique, F-92141 Clamart, France; and Institut Federatif de Recherche 13 (R.L., H.C., C.P., A.-C.D., R.F., R.H., V.R.-F.), F-92141 Clamart, France

Address all correspondence and requests for reprints to: Romain Lambrot, Institut National de la Santé et de la Recherche Médicale U 566, Commissariat à l’Energie Atomique, Université Paris 7, Route du Panorama BP 6, 92265 Fontenay-aux-Roses Cedex, France. E-mail: romain.lambrot{at}cea.fr; or virginie.rouiller-fabre{at}cea.fr.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Context: In human, the chronology of the testicular development has been extensively studied, but the factors implicated in the onset and the regulation of gametogenesis and steroidogenesis remain hardly known.

Objectives: To identify these factors, we developed an organ culture system for human fetal testes recovered during the first trimester (6–12 wk) of gestation. We first aimed at investigating the characteristics of this system by comparing the in vivo and in vitro gametogenesis and steroidogenesis. Second, we used organ culture to investigate the effect on the human testicular functions of retinoic acid (RA), previously described as a regulator of gonadal development in rodents.

Results: Organ culture proved to be an efficient tool for studying the early development of the testicular functions. Indeed, this system was able to maintain satisfactory development of the germ cells and Leydig cells in the absence of any added factor. For older fetuses, the number of germ cells decreased in culture and the LH was necessary to maintain the steroidogenic activity. The addition of 10–6 M RA decreased the total number of germ cells in the fetal testis at all studied stages. This resulted from an increase in apoptosis, which slightly exceeded the increase of proliferation. However, RA had a stimulatory effect on the steroidogenic function for the youngest fetuses over a short period of time by increasing the expression of P450 cholesterol side-chain cleavage, 17 {alpha}-hydroxylase/C17–20 lyase, and steroidogenic acute regulatory protein.

Conclusions: Thus, RA appears as a potential regulator of both gametogenesis and steroidogenesis in human fetal testis. Our organ culture is an interesting tool for studying the effects of various factors on the development of human fetal testis, in particular the effect of hormone-disrupting chemicals.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN RODENTS, THE fetal and neonatal development of the testis involves a succession of well-characterized events, involving each testicular cell type (1). The first step in testis formation is the migration of the primordial germ cells (PGCs) from extraembryonic areas to the genital ridge at about 12.5 d post conception (dpc) in rat (1) and 11.5 dpc in mouse (2). At the same time, the Sertoli cells differentiate and surround the germ cells to form seminiferous cords at 13.5 dpc in rat (3) and 12.5 dpc in mouse (2). The PGCs, which are enclosed in the seminiferous cords, are called gonocytes. These cells proliferate until 17.5 dpc in rat (4) and 15.5 dpc in mouse (5) and then remain quiescent until 2–3 d postnatal in rat (4) and 1 d postnatal in mouse (6). In rat, we have shown that both fetal and neonatal mitosis periods of gonocytes are also periods of apoptosis for these cells (4).

In human, the chronology of the testicular development has also been studied. PGCs start migrating from the stalk of allantois at 4 wk gestation and enter the gonad in the fifth week (7). In males, the PGCs are then enclosed by the differentiating Sertoli cells. Thus, the first morphological sign of testicular differentiation is the formation of testicular cords, which can be seen between 6 and 7 wk gestation (7, 8). The characterization of fetal germ cells was first achieved using electron microscopy and showed the existence of distinct subpopulations (7, 9, 10). Recently an immunohistochemical study using germ cell markers allowed the characterization of three different types of human testicular germ cells: gonocytes, intermediate germ cells, and prespermatogonia (11). However, the changes in the number of germ cells during complete human fetal development and the existence of alternate periods of activity (mitosis and apoptosis) and quiescence have never been reported. The steroidogenic function of human fetal testis is better documented. Steroid-secreting Leydig cells can be seen in the testis at 8 wk gestation (12). Shortly after their appearance, the concentration of androgens in the testicular tissue and blood starts to rise, reaching a maximum at 14–16 wk gestation (13, 14). This increase comes with an increase in the number of Leydig cells (13).

In rodents, there are many factors that regulate these developmental steps. We aimed at developing an organ culture system to study this regulation (15, 16, 17). In this in vitro system, the architecture of the testis and intercellular communications are conserved (18). It also allowed us to mimic the development of Sertoli cells, gonocytes, and Leydig cells that have been observed in vivo with no need to add serum or other factors (15, 16, 17). Using this system, we have shown the importance of vitamin A (retinol) and its biologically active metabolite, retinoic acid (RA), during the development of rat testis (16, 19, 20).

In this present paper, our first aim was to set up an organ culture system to study the development of both gametogenesis and steroidogenesis in human. Then we used this in vitro system to investigate the effects of RA on the development of the human fetal testis because no data are available on the role of RA in the development of the human gonad despite both deficiency and excess of vitamin A being common occurrences (21, 22).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Recovery of human fetal gonads

Human fetal testes were obtained from pregnant women referred to the Department of Obstetrics and Gynecology at the Antoine Béclère Hospital (Clamart, France), for legally induced abortion in the first trimester of pregnancy [6–12 wk gestation (42–84 d)]. The Antoine Béclère Ethics committee approved this study. The termination of pregnancy was induced by treatment with mifegyne (RU 486, Exelgyn, Paris, France; 200 mg orally) followed by aspiration 48 h later. None of the terminations was for reasons of fetal abnormality, and all fetuses appeared morphologically normal. The fetus was dissected under a binocular microscope, and testes were removed aseptically and were immediately explanted in vitro, or fixed in Bouin’s fluid, or placed in TRIzol reagent (Invitrogen, Cergy-Pontoise, France), depending on the subsequent experiment. The sex of the fetus was determined by the morphology of the gonads, and the fetal age was evaluated by measuring the length of limbs and feet (23). We found testes within the abortive material in only 12% of cases.

Organ cultures

Testes were cultured on Millicell-CM Biopore membranes (pore size 0.4 µm; Millipore, Billerica, MA) in Ham F12/DMEM (1:1) (Life Technologies, Inc., Grand Island, NY) containing 80 µg/ml gentamicin (Sigma, St. Louis, MO) as previously described (16). Briefly, testes were cut into small pieces (2, 8, 12, and 16 pieces at 6–7, 8–9, 10, and 11–12 wk gestation, respectively), and all the pieces from the same testis were placed on a single Millicell membrane and floated on 0.3 ml of culture medium in tissue culture dishes and cultured for 4 d at 37 C in a humidified atmosphere containing 95% air-5% CO2. The medium was changed every 24 h. We determined the number of germ cells before and after 4 d of culture by fixing one testis at the time of explantation, whereas the other testis from the same fetus was cultured in medium with no added factor. We measured the response to RA (all-trans, Sigma) by comparing one testis cultured in medium containing RA with the other testis from the same fetus cultured in medium not containing retinoids, as a control. In some cases, for testosterone response to RA, different pieces from the same testis were compared. In some experiments, we added 100 ng/ml LH from human pituitary (≥5000 IU/mg) (Sigma) to either the treated medium or both media for the whole culture period or for the last 3 h of culture. For cellular analyzes, the whole explant was fixed for 2 h in Bouin’s fluid and embedded in paraffin, and 5-µm sections were cut. For gene expression, testes were placed in TRIzol reagent.

Germ cell counting

We mounted serial sections on slides, removed the paraffin, and rehydrated the section. We then carried out immunohistochemical assays for anti-Müllerian hormone (AMH). Therefore, the germ cells were identified as AMH-negative cells within the seminiferous cords, whereas the Sertoli cells were identified as AMH-positive cells. Briefly, sections were incubated with 3% H2O2 in distilled water for 10 min to inactivate endogenous peroxidases. The slides were then washed, blocked for 30 min with normal goat serum followed by incubation for 2 h with the anti-AMH polyclonal antibody (1:2000) [generously provided by Dr. N. Di Clemente (Institut National de la Santé et de la Recherche Médicale U782, Clamart, France)]. We detected this primary antibody with a biotinylated goat antirabbit secondary antibody and the avidin-biotin-peroxidase complex (Vectastain Elite ABC kit; Vector Laboratories, Burlingame, CA). Peroxidase activity was visualized using 3,3'-diaminobenzidine as a substrate. For all immunohistochemical stainings, negative controls were done by omitting the primary antibody. We counted only one of 10 sections for the 6- to 7-wk-old fetuses and one of 20 sections for later stages but never less than 10 sections equidistantly distributed along the testis. All counts were done using Histolab analysis software (Microvision Instruments, Evry, France). We multiplied the sum of the values obtained for the observed sections of one testis by 10 or 20, respectively, to obtain a crude count per testis. We then used the Abercrombie formula (24) to correct for any double counting due to single cells appearing in two successive sections, and so we obtained a true count. All counts were done blind.

Terminal deoxynucleotidyl transferase-mediated deoxyuridine 5-triphosphate nick end labeling (TUNEL) staining

We detected apoptotic cells in situ using the TUNEL method, as previously described (16, 17). We mounted six sections equidistantly distributed along the testis on a single slide. Positive controls were treated with DNase I (100 µg/ml; Sigma) for 10 min at room temperature to induce DNA fragmentation in all the nuclei, and negative controls were incubated without terminal deoxynucleotidyl transferase. TUNEL-positive and -nonpositive germ cells were counted in all six sections.

Immunohistochemical staining for cleaved caspase-3

Caspase-3 is involved in most of the apoptotic pathways (25). Therefore, we used it as a second marker of apoptosis. As for the TUNEL staining, we mounted six sections on a single slide and heated the slide in a permeabilization solution [0.05 M Tris (pH 10.6)] for 30 min. The procedure was then the same as for detection of AMH except that the primary antibody was the anticleaved caspase-3 antibody (1:50; Cell Signaling Technology, Beverly, MA). Stained and unstained germ cells were counted in all six sections.

Immunohistochemical staining for Ki67

Ki67 is a nuclear antigen present only in cycling cells (26). Therefore, we used it as a marker of germ cell proliferation. We mounted six sections on a single slide and heated the slide in a permeabilization solution [0.01 M sodium acetate (pH 2)] for 30 min. The procedure was then the same as for detection of AMH except that normal horse serum and biotinylated horse antimouse secondary antibody were used. The monoclonal anti-Ki67 antibody (1:50) was purchased from Dako (Trappes, France).

Double staining using VIP

After the first immunohistochemical staining (TUNEL, cleaved caspase-3, Ki67) revealed with 3,3'-diaminobenzidine, the sections were washed in PBS for 10 min, processed for AMH immunohistochemical staining as previously described, and visualized using VIP as a peroxidase substrate (Vector Laboratories).

Testosterone RIA

We measured the testosterone secreted into the medium in duplicate by RIA as previously described (15). No extraction or chromatography was performed because 17ß-hydroxy-5{alpha}-androstan-3-one, the only steroid that significantly cross-reacts with testosterone (64%), is secreted in minute amounts by the human fetal testis (27).

Reverse transcription and real-time PCR

We evaluated the expression of P450 cholesterol side-chain cleavage (P450SCC), P450 17{alpha}-hydroxylase/C17–20 lyase (P450C17), and steroidogenic acute regulatory protein (StAR) in fetal testes by a reverse transcription followed by a real-time PCR (real-time RT-PCR). At the end of the culture period, total RNA was extracted from fetal testes with the TRIzol reagent according to the manufacturer’s instructions. RNAs were quantified by using the RiboGreen RNA quantitation kit (Molecular Probes, Cergy-Pontoise, France), and 50 ng of total testicular RNA was reverse transcribed. The primers and probes used were assays on demand designed by Applied Biosystems (Courtaboeuf, France) (sequences not provided, P450scc, Hs00167984_m1; P450c17, Hs00164375_m1; StAR, Hs00264912_m1; ß-actin, Hs99999903_m1; ARN 18S, Hs99999901_s1). Reactions were carried out and fluorescence was detected on an ABI Prism 7000 apparatus (Applied Biosystems, Foster City, CA). Each sample was run in duplicate, and a control PCR was also carried out with RNA for each sample. Negative controls were run for every primer/probe combination. The measured amount of each cDNA was normalized using ß-actin and ARN 18S to confirm.

Statistical analysis

All values are expressed as means ± SEM. The significance of the differences between mean values for the treated and untreated testes was evaluated using Student’s paired t test. Other means were compared by one-way ANOVA (Tukey-Kramer’s test).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Morphogenesis of the human fetal testis in vitro

We removed testes from fetuses at about 6 wk of development to 10 wk. For each fetus, we fixed one testis at the time of explantation (Fig. 1Go, A and C) and cultured the other testis for 4 d in control medium. After culture (Fig. 1Go, B and D), the architecture of the testis was well conserved, and Sertoli cells were aggregated in cords and surrounded germ cells. AMH was still expressed at a high level by Sertoli cells. We also observed no sign of necrosis or disorganized areas in the tissue. The germ cells displayed large, spherical nuclei containing two or more globular nucleoli and a clearly visible cytoplasm that corresponds to gonocyte morphology (Fig. 1Go, A–F).


Figure 1
View larger version (170K):
[in this window]
[in a new window]
 
FIG. 1. Histological appearance of the human fetal testis before and after 4 d of culture. Explants from 6-wk (A and B) and older than 10-wk (C and D) fetuses were fixed in Bouin’s fluid immediately after removal (A and C) or cultured on Millipore membranes (B, D, and E). The Sertoli cells (arrowheads) were identified using immunohistochemistry with a polyclonal anti-AMH antibody, which also allowed us to distinguish the unstained germ cells (arrow) in the seminiferous cords. A negative control of the immunostaining was performed by replacing the first antibody by PBS (F). Bars, 10 µm.

 
Germ cell development in vitro

We evaluated the number of germ cells and their mitotic and apoptotic indices after 4 d of culture and compared these with the values obtained at the time of explantation. For testes explanted before or at 7 wk, the number of germ cells remained the same before and after culture, whereas it decreased 1.8 times for testis explanted at more than 7 wk (Fig. 2AGo). The proliferation detected by the immunostaining of Ki67 was increased significantly only for the oldest ones (Fig. 2BGo). However, we observed cleaved caspase-3-positive germ cells at explantation, and their percentage tended to increase in culture for young fetuses and increased significantly for more than 7-wk fetuses (Fig. 2CGo).


Figure 2
View larger version (15K):
[in this window]
[in a new window]
 
FIG. 2. Germ cell development in vitro. One testis from 6- to 7-wk or older than 7-wk-old fetuses was cultured for 4 d in control medium. The other testis from the same fetus was fixed in Bouin’s fluid. At the time of explantation and at the end of the culture, germ cells were identified indirectly using AMH immunohistochemical staining, and the total number of germ cells was counted (A). Proliferation was determined by immunohistochemical staining of the nuclear antigen Ki67 (B). Apoptosis was revealed by the immunohistochemical staining of the cleaved caspase-3 (C). Means ± SEM of three or six determinations are shown. *, P < 0.05 in the paired statistical comparison with the corresponding control values.

 
Testosterone production by human fetal testis in vitro

We cultured testes from fetuses at 6–12 wk of development for 4 d in control medium, and we measured the daily testosterone secretion directly in the medium. The secretion profiles differed as a function of the age of the fetus at the time of explantation (Fig. 3Go, A–C). At 6 wk of development, testosterone production increased significantly during the culture period from 12 ± 2.5 pg/testis per hour at d 1 to 36.4 ± 11.5 pg/testis per hour at d 4 (Fig. 3AGo). For testes explanted from fetuses between 6 and 7 wk of development, testosterone secretion remained constant at about 120 pg/testis per hour for the 4 d of culture (Fig. 3BGo). For testes from later stages (more than 7 wk to 12 wk), the testosterone production was much higher than for testes explanted at earlier stages of development (9.6 ± 2.3 ng/testis per hour) and greatly and significantly decreased after the first day of culture and more so during the 2 following days (Fig. 3CGo). We added LH (100 ng/ml) to the culture medium for some of the testes from d 2 until the end of the culture. We then assayed basal or LH-stimulated testosterone production. LH increased the production of testosterone during the whole culture (Fig. 3DGo), avoiding the Leydig cell dedifferentiation.


Figure 3
View larger version (31K):
[in this window]
[in a new window]
 
FIG. 3. Testosterone secretion by human fetal testes in organ culture. Explants of testes from 6-wk, between 6- and 7-wk, and greater than 7-wk-old fetuses were cultured for 4 d in control medium (A, B, and C). The media were changed every 24 h and their testosterone content was measured by RIA. Values are means ± SEM of four to 26 determinations. For explants from 7- to 12-wk fetuses (D), one piece of a testis from each fetus was cultured in control medium and the other one in medium supplemented with 100 ng/ml LH from 24 to 96 h. Data are expressed as a percentage of testosterone secretion at d 1 with the value of this day taken as 100%. Means ± SEM of three determinations are shown. *, P < 0.05 in the paired statistical comparison with the corresponding control values. a, P < 0.05; b, P < 0.01; c, P < 0.001 in the comparison with the first day of culture (ANOVA test).

 
Effect of RA on testis morphogenesis and germ cell development

We cultured testes from fetuses at about 6 wk of development to 10 wk with or without 10–6 M of RA for 4 d. RA had no effect on the organization of the testis, and the appearance of all cells was similar to the control. We then evaluated the number of germ cells and their mitotic and apoptotic indices. Irrespective of the age, RA reduced the number of germ cells. Therefore, we pooled the results from different ages (Fig. 4AGo). RA treatment increased significantly both the mitotic index and percentage of TUNEL-positive and cleaved caspase-3-positive germ cells (Fig. 4Go, B–D).


Figure 4
View larger version (21K):
[in this window]
[in a new window]
 
FIG. 4. Effect of RA on the proliferation of the germ cells. Testes from 6- to 10-wk-old fetuses were cultured for 4 d. One testis from each fetus was cultured in control medium and the other in medium supplemented with 10–6 M RA. The number of germ cells with or without RA treatment was determined (A). Proliferation was determined by immunohistochemical staining of the nuclear antigen Ki67 (B). Fragmentation of the DNA was determined using the TUNEL method (C). Apoptosis was shown by immunohistochemical staining of the cleaved caspase-3 (D). In all cases (A–D), an AMH immunostaining was carried out to identify germ cells. For A, data are expressed as a percentage with the value of the control testis taken as 100%. Means ± SEM of 13 determinations are shown. For B, C, and D, values are means ± SEM of five to seven determinations. *, P < 0.05; **, P < 0.01, in the paired statistical comparison with the corresponding control values.

 
Effect of RA on steroidogenesis

We cultured testes from fetuses under 7 wk of development and older with or without 10–6 M of RA for 4 d. RA treatment increased testosterone production, compared with control testes at d 2 and 3 for testis under 7 wk (Fig. 5AGo). This stimulating effect disappeared at d 4. For testes from fetuses of more than 7 wk, RA treatment had no effect on steroidogenesis (Fig. 5BGo). Even when LH (100 ng/ml) was added to the medium of both control and treated testis, RA treatment still had no effect on testosterone production (Fig. 5CGo).


Figure 5
View larger version (16K):
[in this window]
[in a new window]
 
FIG. 5. Effect of RA on testosterone secretion by human fetal testes. Testicular explants from fetuses of less than or equal to 7 wk (A) and more than 7 wk of development (B) were cultured for 24 h in control medium and 3 more days in the presence or absence of RA (10–6 M). Other explants from fetuses of more than 7 wk development were cultured in the same conditions with all the media being supplemented with 100 ng/ml LH (C). Testosterone production was corrected by the production on d 1 and expressed as a percentage of the control with the value of the control testes taken as 100% at every day. Means ± SEM of seven to 12 determinations are shown. **, P < 0.01 in the paired statistical comparison with the corresponding control values.

 
Effect of RA on steroidogenic enzyme mRNA levels

We analyzed by real-time RT-PCR the effect of RA on the levels of mRNA for P450SCC, P450C17, and StAR after 2 d of culture (Fig. 6Go). We used testes from fetuses under 7 wk and after 7 wk because at these stages, testes show RA-stimulated and RA-independent testosterone secretion, respectively. For testes from fetuses under 7 wk, RA treatment increased significantly the mRNA levels of all of these enzymes, whereas for testes from fetuses after 7 wk of development, RA treatment no longer had an effect on the mRNA expression.


Figure 6
View larger version (21K):
[in this window]
[in a new window]
 
FIG. 6. Effect of RA on steroidogenic enzymes mRNA levels. Explants from fetuses of less than or equal to 7 wk (left) and more than 7 wk (right) of development were cultured for 4 d. One testis from each fetus was cultured in control medium and the other in medium supplemented with 10–6 M RA. Total RNA was extracted and real-time RT-PCR with specific primers was carried out to analyze the expression of the genes encoding P450SCC, P450C17, and StAR. We used ß-actin and ARN 18S as control. Data are expressed as a percentage, with the values for the control testes taken as 100%. Means ± SEM of three or four determinations for each period are shown. *, P < 0.05.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In this study we developed an organ culture system for the human fetal testes. We used it to investigate the role of retinoids on the development of germ cells and the steroidogenic function.

We previously developed an organ culture system for fetal and neonatal rat testes (15, 16). This system allowed us to demonstrate that several factors, hormones, and vitamins can modulate the proliferation of germ cells and the functional development of somatic cells (16, 17, 20). This system is the most suitable for human due to the limited available quantity of material. Moreover, in human, in vitro studies are the only possible experimental studies. We first aimed at investigating the characteristics of this system by comparing in vivo and in vitro gametogenesis and steroidogenesis. From in vivo studies, it is known that during the first trimester of pregnancy, the number of germ cells, mostly identified as gonocytes (11), increases continuously (28). In our culture system, we observed that germ cell number was maintained for young fetuses (≤7 wk). Thus, early differentiating human fetal testis is able to produce the factors needed to sustain gametogenesis. For explanted testes at later stages (older than 7 wk to 12 wk), the number of germ cells was reduced. This is due to increased apoptosis slightly exceeding the increase in the mitotic activity. In our study we determined the total number of germ cells before and after culture, which allows us to characterize the biology of the germ cells in vitro. Previous studies using organ cultures in human determined only the density of germ cells (29) or did not even study this parameter (30). However, the human fetal testis is highly heterogeneous with large variations in germ cell density within the organ (28). Therefore, the number of germ cells needs to be determined for the whole testis.

We also focused on testosterone secretion. We observed three different secretion profiles, depending on the age of the fetuses. For testes from fetuses before 7 wk gestation, testosterone secretion increased during the culture period. This is consistent with in vivo observations. Indeed, testosterone can be detected from 6 to 7 wk gestation (31), and its serum concentration then increases until 14–16 wk gestation (13, 14). Our results also show that early testosterone production does not appear to be controlled by extratesticular factors because nothing was added to the culture medium. This confirms that neither human chorionic gonadotropin (hCG) nor LH control initial Leydig cell differentiation, which is consistent with the study by Kremer et al. (32) on an inactivating LH receptor-mutated patient who displayed some development of the Wolffian ducts. Over a small range of gestational age (~6–7 wk gestation), testosterone secretion remained constant during the culture period in our system. For later developmental stages, testosterone secretion fell. Therefore, an essential factor for testosterone secretion in vitro appeared to be missing. In human, before testicular development, hCG is secreted by the placenta and LH is produced by the pituitary gland as early as the 10th wk (14). Hence, we added LH to the culture medium and observed a constant or even increasing testosterone secretion. So we indeed observed the LH/hCG stimulatory effect that was seen by Huhtaniemi et al. (33) on minces of human fetal testis. These results do not agree with a previous study by Abramovich et al. (34) that showed that hCG did not maintain testosterone secretion in culture. However, our results confirm that hCG/LH is absolutely required for maintaining testosterone secretion after the seventh week (13).

The second purpose of our study was to use this organ culture system to study the effect of RA on human testis development. RA is an important regulator of fetal development in many organs. Previous studies have also shown that retinoids have many effects on the development and/or function of the three main cell types in rodent fetal and neonatal testis (16). In human, there is often a deficiency or excess of vitamin A or retinol. Severe vitamin A deficiency is observed in most developing countries, and an insufficient intake of vitamin A has been reported for 20–25% of adult women in Paris (21). Conversely, hyperretinoidemia is frequently provoked for therapeutic purposes (22). Therefore, we tested the effect of adding 10–6 M of RA on testis in culture. We chose this dose according to our previous studies on rat fetal testis. In addition studies on the endogenous distribution of retinoids during normal development in whole mouse embryos showed that there was a 5- to 10-fold excess in concentration of retinol, compared with RA (35). In human fetuses, there have been no studies on retinol concentration, although Berggren Soderlund et al. (36) showed that human newborns have serum retinol concentration of 10–6 M. Therefore, 10–6 M RA appeared appropriate to produce a clear result without any toxic effect.

Although RA causes disruption of the seminiferous cords in the testis of rat fetuses at 14.5 dpc (16), we observed no disorganization in human testis.

After 3 d of treatment, RA reduced the number of germ cells in human fetal testis. This was also observed in 14.5 dpc rat (16) and 12.5 dpc mouse (Livera, G., and V. Rouiller-Fabre, unpublished data).

We also found that, as in rat, this effect was due to a large increase in apoptosis that greatly exceeded the increase in mitosis. This is consistent with the apoptotic effect of retinoids in many other cell types or lines (37, 38). Whether RA acts on germ cells directly or via autocrine/paracrine factors and the types of receptors and pathways that are implicated remain to be investigated.

The effect of RA on germ cells was reproducible at all stages of development studied, confirming that our in vitro culture system allows us to study the effects of different factors on germ cells from 6 to 12 wk of fetal development.

RA also had a stimulatory effect on the steroidogenic function over a short period of time. This period corresponds to the period in which testosterone secretion spontaneously increased or remained constant in culture without any stimulation. After this period, RA had no effect on testosterone secretion irrespective of whether LH was added to the culture medium. The effect, which was still present after 3 d of culture, disappeared on the fourth day, i.e. the third day of RA treatment. This showed that RA is an early and transient regulator of testosterone secretion.

When RA stimulated testosterone secretion, the levels of three enzymes involved in steroidogenesis were increased, whereas when RA had no effect, the levels of these enzymes remained unchanged. In rat, RA reduces testosterone secretion by only decreasing the level of P450C17 (20).

In conclusion, our study has shown that our in vitro organ culture system is a powerful tool for studying the development of the human fetal testis. It enabled us to show that RA is a potential regulator of germ cell proliferation and steroidogenesis during the first trimester of pregnancy.

Recently several studies have linked male reproductive disorders in human, such as decreasing male fertility (39), increasing incidence of testicular cancer (40), and cryptorchidism and hypospadias (41) with exposure to hormone-disrupting chemicals. These chemicals may alter male fertility by acting early in gonad development. Thus, our organ culture system appears particularly suitable to study the effect of potential toxic substances on human fetal testis development.


    Acknowledgments
 
We thank the staff of the Department of Obstetrics and Gynecology of the Antoine Béclère Hospital. We are grateful to N. Di Clemente for donating the antibody anti-AMH. We also thank C. Racine, E. Moreau, and F. Djouadi for their help with RT-PCR study.


    Footnotes
 
This work was supported by Institut National de la Santé et de la Recherche Médicale, Commissariat à l’Energie Atomique, Université Paris 7, Electricité De France, the Toxicologie Nucléaire Environnementale program, and the Agence Française de Sécurité Sanitaire de l’Environnement et du Travail. R.L. holds a fellowship from the Commissariat à l’Energie Atomique.

R.L., H.C., C.P., A.-C.D., R.H., and V.R.-F. have nothing to declare, R.F. received lecture fees from different pharmaceutical companies that are not directly related to the material being published.

First Published Online April 18, 2006

Abbreviations: AMH, Anti-Müllerian hormone; dpc, days post conception; hCG, human chorionic gonadotropin; P450C17, P450 17{alpha}-hydroxylase/C17–20 lyase; PGC, primordial germ cell; P450SCC, P450 cholesterol side-chain cleavage; RA, retinoic acid; StAR, steroidogenic acute regulatory protein; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine 5-triphosphate nick end labeling.

Received September 23, 2005.

Accepted April 6, 2006.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Brennan J, Capel B 2004 One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 5:509–521[Medline]
  2. Anderson R, Garcia-Castro M, Heasman J, Wylie C 1998 Early stages in males germ cell differentiation in the mouse. APMIS 106:127–133[Medline]
  3. Magre S, Jost A 1980 The initial phases of testicular organogenesis in the rat. An electron microscopy study. Arch Anat Microsc Morphol Exp 69:297–318[Medline]
  4. Olaso R, Habert R 2000 Genetic and cellular analysis of male germ cell development. J Androl 21:497–511[Abstract]
  5. Vergouwen RP, Jacobs SG, Huiskamp R, Davids JA, de Rooij DG 1991 Proliferative activity of gonocytes, Sertoli cells and interstitial cells during testicular development in mice. J Reprod Fertil 93:233–243[Abstract/Free Full Text]
  6. Nagano R, Tabata S, Nakanishi Y, Ohsako S, Kurohmaru M, Hayashi Y 2000 Reproliferation and relocation of mouse male germ cells (gonocytes) during prespermatogenesis. Anat Rec 258:210–220[Medline]
  7. Wartenberg H 1989 Differentiation and development of the testes. In: Burger Had KD, ed. The testis. New York: Raven Press; 67–118
  8. Gondos B 1980 Development and differentiation of the testis and male reproductive tract. In: Steinberger A, Steinberger E, eds. Testicular development, structure, and function. New York: Raven Press; 3–20
  9. Fukuda T, Hedinger C, Groscurth P 1975 Ultrastructure of developing germ cells in the fetal human testis. Cell Tissue Res 161:55–70[Medline]
  10. Hilscher B, Hilscher W, Bulthoff-Obnolz B, Krämer U, Birke A, Pelzer H, Grauss G 1974 Kinetics of gametogenesis. I. Comparative histological and autoradiographic studies of oocytes and transitional prospermatogonia during oogenesis and prespermatogenesis. Cell Tissue Res 154:443–470[Medline]
  11. Gaskell TL, Esnal A, Robinson LL, Anderson RA, Saunders PT 2004 Immunohistochemical profiling of germ cells within the human fetal testis: identification of three subpopulations. Biol Reprod 71:2012–2021[Abstract/Free Full Text]
  12. Huhtaniemi I, Pelliniemi L 1992 Fetal Leydig cells: cellular origin, morphology, life span, and special functional features. Proc Soc Exp Biol Med 201:125–140[CrossRef][Medline]
  13. Rabinovici J, Jaffe R 1990 Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 11:532–557[Abstract/Free Full Text]
  14. Reyes F, Winter J, Faiman C 1989 Endocrinology of the fetal testis. In: Burger H, de Kretser D, eds. The testis. 2nd ed., New York: Raven Press; 119–142
  15. Habert R, Devif I, Gangnerau MN, Lecerf L 1991 Ontogenesis of the in vitro response of rat testis to gonadotropin-releasing hormone. Mol Cell Endocrinol 82:199–206[CrossRef][Medline]
  16. Livera G, Rouiller-Fabre V, Durand P, Habert R 2000 Multiple effects of retinoids on the development of Sertoli, germ and Leydig cells of fetal and neonatal rat testis in culture. Biol Reprod 62:1303–1314[Abstract/Free Full Text]
  17. Olaso R, Pairault C, Boulogne B, Durand P, Habert R 1998 Transforming growth factor ß1 and ß2 reduce the number of gonocytes by increasing apoptosis. Endocrinology 139:733–740[Abstract/Free Full Text]
  18. Rouiller-Fabre V, Levacher C, Pairault C, Racine C, Moreau E, Olaso R, Livera G, Migrenne S, Delbes G, Habert R 2003 Development of the foetal and neonatal testis. Andrologia 35:79–83[CrossRef][Medline]
  19. Livera G, Rouiller-Fabre V, Pairault C, Levacher C, Habert R 2002 Regulation and perturbation of testicular functions by vitamin A. Reproduction 124:173–180[Abstract]
  20. Livera G, Pairault C, Lambrot R, Lelievre-Pegorier M, Saez JM, Habert R, Rouiller-Fabre V 2004 Retinoid-sensitive steps in steroidogenesis in fetal and neonatal rat testes: in vitro and in vivo studies. Biol Reprod 70:1814–1821[Abstract/Free Full Text]
  21. Hercberg S, Preziosi P, Galan P, Devanlay M, Keller H, Bourgeois C, Potier de Courcy G, Cherouvrier F 1994 Vitamin status of a healthy French population: dietary intakes and biochemical markers. Int J Vitam Nutr Res 64:220–232[Medline]
  22. Dragnev KH, Rigas JR, Dmitrovsky E 2000 The retinoids and cancer prevention mechanisms. Oncologist 5:361–368[Abstract/Free Full Text]
  23. Evtouchenko L, Studer L, Spenger C, Dreher E, Seiler RW 1996 A mathematical model for the estimation of human embryonic and fetal age. Cell Transplant 5:453–464[CrossRef][Medline]
  24. Abercrombie M 1946 Estimation of nuclear population from microtome sections. Anat Rec 94:238–248
  25. Omezzine A, Chater S, Mauduit C, Florin A, Tabone E, Chuzel F, Bars R, Benahmed M 2003 Long-term apoptotic cell death process with increased expression and activation of caspase-3 and -6 in adult rat germ cells exposed in utero to flutamide. Endocrinology 144:648–661[Abstract/Free Full Text]
  26. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes J 1993 The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123:513–522[Abstract/Free Full Text]
  27. George FW, Carr BR, Noble JF, Wilson JD 1987 5{alpha}-Reduced androgens in the human fetal testis. J Clin Endocrinol Metab 64:628–630[Abstract/Free Full Text]
  28. Bendsen E, Byskov AG, Laursen SB, Larsen HP, Andersen CY, Westergaard LG 2003 Number of germ cells and somatic cells in human fetal testes during the first weeks after sex differentiation. Hum Reprod 18:13–18[Abstract/Free Full Text]
  29. Robinson LL, Townsend J, Anderson RA 2003 The human fetal testis is a site of expression of neurotrophins and their receptors: regulation of the germ cell and peritubular cell population. J Clin Endocrinol Metab 88:3943–3951[Abstract/Free Full Text]
  30. Bendsen E, Laursen S, Olesen C, Westergaard L, Andersen C, Byskov A 2001 Effect of 4-octyphenol on germ cell number in cultured human fetal gonads. Hum Reprod 16:336–343
  31. Tapanainen J, Kellokumpu-Lehtinen P, Pelliniemi L, Huhtaniemi I 1981 Age-related changes in endogenous steroids of human fetal testis during early and mid pregnancy. J Clin Endocrinol Metab 52:98–102[Abstract/Free Full Text]
  32. Kremer H, Kraaij R, Toledo SPA, Post M, Fridman JB, Hayashida CY, Van Reen M, Milgrom E, Ropers HH, Mariman E, Themmen APN, Brunner THG 1995 Male pseudohermaphroditism due to a homozygous missense mutation of luteinizing hormone receptor gene. Nat Genet 9:160–164[CrossRef][Medline]
  33. Huhtaniemi IT, Korenbrot CC, Jaffe RB 1977 HCG binding and stimulation of testosterone biosynthesis in the human fetal testis. J Clin Endocrinol Metab 44:963–967[Abstract/Free Full Text]
  34. Abramovich DR, Baker TG, Neal P 1974 Effect of human chorionic gonadotrophin on testosterone secretion by the foetal human testis in organ culture. J Endocrinol 60:179–185[Abstract/Free Full Text]
  35. Horton C, Maden M 1995 Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo. Dev Dyn 202:312–323[Medline]
  36. Berggren Soderlund M, Fex GA, Nilsson-Ehle P 2005 Concentrations of retinoids in early pregnancy and in newborns and their mothers. Am J Clin Nutr 81:633–636[Abstract/Free Full Text]
  37. Mehta K, McQueen T, Neamati N, Collins S, Andreeff M 1996 Activation of retinoid receptors RAR{alpha} and RXR{alpha} induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ 7:179–186[Abstract]
  38. Jimenez-Lara AM, Clarke N, Altucci L, Gronemeyer H 2004 Retinoic-acid-induced apoptosis in leukemia cells. Trends Mol Med 10:508–515[CrossRef][Medline]
  39. Sharpe RM, Irvine DS 2004 How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ 328:447–451[Free Full Text]
  40. Adami HO, Bergstrom R, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Ziegler H, Rahu M, Gurevicius R, Stengrevics A 1994 Testicular cancer in nine northern European countries. Int J Cancer 59:33–38[Medline]
  41. Sharpe RM 2003 The ‘oestrogen hypothesis’—where do we stand now? Int J Androl 26:2–15[CrossRef][Medline]



This article has been cited by other articles:


Home page
Hum ReprodHome page
M.-J. Guerquin, C. Duquenne, H. Coffigny, V. Rouiller-Fabre, R. Lambrot, M. Bakalska, R. Frydman, R. Habert, and G. Livera
Sex-specific differences in fetal germ cell apoptosis induced by ionizing radiation
Hum. Reprod., March 1, 2009; 24(3): 670 - 678.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Gondo, T. Okabe, T. Tanaka, H. Morinaga, M. Nomura, R. Takayanagi, H. Nawata, and T. Yanase
Adipose Tissue-Derived and Bone Marrow-Derived Mesenchymal Cells Develop into Different Lineage of Steroidogenic Cells by Forced Expression of Steroidogenic Factor 1
Endocrinology, September 1, 2008; 149(9): 4717 - 4725.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Jahnukainen, J. Ehmcke, M. Nurmio, and S. Schlatt
Irradiation Causes Acute and Long-Term Spermatogonial Depletion in Cultured and Xenotransplanted Testicular Tissue from Juvenile Nonhuman Primates
Endocrinology, November 1, 2007; 148(11): 5541 - 5548.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. A. Fowler, D. R. Abramovich, N. E. Haites, P. Cash, N. P. Groome, A. Al-Qahtani, T. J. Murray, and R. G. Lea
Human fetal testis Leydig cell disruption by exposure to the pesticide dieldrin at low concentrations
Hum. Reprod., November 1, 2007; 22(11): 2919 - 2927.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Lambrot, H. Coffigny, C. Pairault, C. Lecureuil, R. Frydman, R. Habert, and V. Rouiller-Fabre
High Radiosensitivity of Germ Cells in Human Male Fetus
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2632 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Merlet, C. Racine, E. Moreau, S. G. Moreno, and R. Habert
Male fetal germ cells are targets for androgens that physiologically inhibit their proliferation
PNAS, February 27, 2007; 104(9): 3615 - 3620.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lambrot, R.
Right arrow Articles by Rouiller-Fabre, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lambrot, R.
Right arrow Articles by Rouiller-Fabre, V.
Related Collections
Right arrow Male Endocrinology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals